brachytherapy, prostate cancer, monotherapy, EBRT, hypofractionation, SBRT, side effects, QOL, quality of life, IPSS, meta-analysis, HDR, LDR, urinary adverse events, ASCENDE-RT, DE-EBRT, LDR-PB, FLAME, toxicity profile, IMRT, SHORT, Gy, HR prostate cancer, risk groups, cell survival, radiation dose, dose distribution, iodine 125 suppliers, seeds, HDR brachytherapy flow chart, dosimetry, intermediate risk, BT Boost, randomised trials, long term outcomes, MRL, guided LINACs, Afterloader